Ivan D Horak Selected Research

Ivan D Horak Research Topics

Disease

39	Neoplasms (Cancer) 01/2022 - 01/2004
8	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 09/2005
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2009 - 04/2004
3	Breast Neoplasms (Breast Cancer) 03/2015 - 03/2004
3	Hypoxia (Hypoxemia) 09/2011 - 11/2008
3	Carcinoma (Carcinomatosis) 06/2011 - 04/2005
3	Neoplasm Metastasis (Metastasis) 11/2008 - 04/2005
3	Lymphoma (Lymphomas) 12/2005 - 12/2003
3	Colonic Neoplasms (Colon Cancer) 11/2005 - 04/2005
2	Neuroblastoma 01/2022 - 10/2010
2	Glioma (Gliomas) 01/2022 - 09/2011
2	Residual Neoplasm 01/2020 - 04/2005
2	Glioblastoma (Glioblastoma Multiforme) 07/2018 - 11/2008
2	Stomach Neoplasms (Stomach Cancer) 01/2018 - 01/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016 - 10/2013
2	B-Cell Lymphoma (Lymphoma, B Cell) 08/2005 - 12/2003
2	Multiple Myeloma 07/2005 - 12/2004
1	Hodgkin Disease (Hodgkin's Disease) 01/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021
1	Triple Negative Breast Neoplasms 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2016
1	Prostatic Neoplasms (Prostate Cancer) 12/2011
1	Necrosis 10/2010

Drug/Important Bio-Agent (IBA)

9	AntibodiesIBA 01/2022 - 04/2005
9	ErbB Receptors (EGF Receptor)IBA 01/2020 - 06/2011
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2004
9	Monoclonal AntibodiesIBA 04/2018 - 03/2004
7	Pharmaceutical PreparationsIBA 01/2018 - 12/2003
5	LigandsIBA 01/2020 - 12/2011
5	Irinotecan (Camptosar)FDA LinkGeneric 09/2011 - 04/2005
5	Carcinoembryonic AntigenIBA 11/2005 - 04/2005
4	Cetuximab (Erbitux)FDA Link 01/2021 - 10/2013
4	futuximabIBA 07/2018 - 10/2013
4	Messenger RNA (mRNA)IBA 11/2017 - 11/2008
4	EZN-2208IBA 09/2011 - 03/2008
4	Immunoglobulin G (IgG)IBA 12/2005 - 04/2005
3	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 07/2005
3	LuciferasesIBA 12/2011 - 10/2010
3	HaptensIBA 11/2005 - 10/2005
3	Radioisotopes (Radionuclides)IBA 10/2005 - 04/2005
3	Rituximab (Mabthera)FDA Link 08/2005 - 04/2004
3	AntigensIBA 04/2005 - 04/2004
2	RNA (Ribonucleic Acid)IBA 01/2020 - 11/2008
2	EpitopesIBA 12/2017 - 10/2013
2	Trastuzumab (Herceptin)FDA Link 11/2017 - 03/2015
2	Neutralizing AntibodiesIBA 11/2017 - 04/2013
2	Tyrosine Kinase InhibitorsIBA 04/2013 - 06/2011
2	Phosphotransferases (Kinase)IBA 04/2013 - 06/2011
2	Lapatinib (GW572016)FDA Link 04/2013 - 06/2011
2	Transcription Factors (Transcription Factor)IBA 12/2011 - 11/2008
2	Antisense OligonucleotidesIBA 12/2011 - 02/2010
2	Topoisomerase I InhibitorsIBA 09/2011 - 10/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2011 - 10/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2010 - 07/2005
2	ProdrugsIBA 10/2010 - 04/2008
2	Immunotoxins (Immunotoxin)IBA 12/2005 - 05/2005
2	Peptides (Polypeptides)IBA 11/2005 - 11/2005
2	epratuzumabIBA 08/2005 - 04/2004
2	Complement System Proteins (Complement)IBA 04/2005 - 04/2004
2	IodineIBA 04/2005 - 03/2004
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Insulin-Like PeptidesIBA 01/2021
1	BuffersIBA 01/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	human ERBB2 proteinIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2019
1	epidermal growth factor receptor VIIIIBA 07/2018
1	Circulating Tumor DNAIBA 04/2018
1	emibetuzumabIBA 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	Neuregulin-1 (Neuregulin 1)IBA 11/2017
1	Panitumumab (Vectibix)FDA Link 06/2015
1	pertuzumabIBA 03/2015
1	Caspase 3 (Caspase-3)IBA 10/2013
1	Gefitinib (Iressa)FDA Link 04/2013
1	5'-ACCaagtttcttcAGC-3'IBA 12/2011
1	enzalutamideIBA 12/2011
1	AndrogensIBA 12/2011
1	Androgen Receptors (Androgen Receptor)IBA 12/2011
1	abirateroneIBA 12/2011
1	Testosterone (Sustanon)FDA Link 12/2011
1	matrigelIBA 09/2011
1	Matrix Metalloproteinases (MMPs)IBA 10/2010
1	Histones (Histone)IBA 10/2010
1	Therapeutic UsesIBA 10/2010
1	Vincristine (Oncovin)FDA LinkGeneric 10/2010
1	Cisplatin (Platino)FDA LinkGeneric 10/2010
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 10/2010
1	Topotecan (Hycamtin)FDA LinkGeneric 10/2010
1	FenretinideIBA 10/2010
1	SurvivinIBA 02/2010
1	EZN 3042IBA 02/2010

Therapy/Procedure

20	Therapeutics 01/2022 - 03/2004
5	Radioimmunotherapy 11/2005 - 03/2004
3	Aftercare (After-Treatment) 01/2020 - 09/2011
2	Immunotherapy 01/2022 - 01/2019
2	Drug Therapy (Chemotherapy) 08/2005 - 04/2005
1	Castration 12/2011